Sunbeam Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1M Sell
6,899
-499
-7% -$69K 0.46% 43
2026
Q2
$951K Buy
7,398
+67
+0.9% +$7.84K 0.43% 48
2026
Q1
$882K Buy
7,331
+232
+3% +$26.8K 0.5% 40
2025
Q4
$747K Buy
7,099
+94
+1% +$8.82K 0.44% 46
2025
Q3
$594K Buy
7,005
+43
+0.6% +$3.54K 0.37% 49
2025
Q2
$557K Buy
6,962
+762
+12% +$60.6K 0.42% 45
2025
Q1
$561K Buy
6,200
+34
+0.6% +$3.17K 0.53% 35
2024
Q4
$613K Buy
+6,166
New +$636K 0.57% 34

Other funds holding MRK

Sunbeam Capital Management's MRK Position: Q3 2026 in Review

Sunbeam Capital Management reduced its Merck (MRK) stake by 6.7% in Q3 2026, selling an estimated $69K and leaving 6,899 shares worth $1M. The position accounts for 0.46% of the portfolio, ranked #43.

Sunbeam Capital Management first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 3,978 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Sunbeam Capital Management held 6,899 shares of Merck worth $1M as of Q3 2026.
  • Sunbeam Capital Management sold 499 Merck shares in Q3 2026, an estimated $69K.
  • Merck made up 0.46% of Sunbeam Capital Management's portfolio in Q3 2026, its #43 holding.
  • Sunbeam Capital Management first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 3,978 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Sunbeam Capital Management's 13F filing for Q3 2026, filed 5 Nov 2026.